SavedAdd your journal

Journals / Türkiye Diyabet ve Obezite Dergisi / 2026 / Cilt: 10 Sayı: 1

Fetal Changes Associated with Hyperglycemic Pregnancies – An Experimental Perspective

Hiperglisemik Gebeliklere Bağlı Fetal Değişiklikler - Deneysel Perspektif

Serkan Karaçetin(ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ, ZONGULDAK SAĞLIK YÜKSEKOKULU)0000-0002-8670-4812
Meryem Akpolat Ferah(ZONGULDAK BULENT ECEVİT UNIVERSITY)0000-0002-3419-1728
Mete Keçeci(ZONGULDAK BULENT ECEVİT UNIVERSITY)0000-0002-2144-4730
Pages
94–106
Publication Date
2026-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review is to provide a general and comparative perspective on the changes induced in the fetus by diabetes, experimentally modeled before and during pregnancy, throughout the gestational period

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hyperglycemia during pregnancy induces a diabetic condition associated with fetal complications.
📊
Key Findings & Data:Examination of the data reveals that fetal losses and adverse fetal outcomes increase in parallel with the prevalence of diabetes mellitus among pregnant women.
💡
Conclusion & Impact:The aim of this review is to provide a general and comparative perspective on the changes induced in the fetus by diabetes, experimentally modeled before and during pregnancy, throughout the gestational period
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Fetal · Gebelik · Hiperglisemi

Abstract

Hyperglycemia during pregnancy induces a diabetic condition associated with fetal complications. Examination of the data reveals that fetal losses and adverse fetal outcomes increase in parallel with the prevalence of diabetes mellitus among pregnant women. Advancing maternal age and the progressive deterioration of living conditions contribute to a rise in hyperglycemic pregnancies and associated adverse fetal changes, ultimately posing a global health risk that may affect future generations. According to data provided by the International Diabetes Federation, approximately 21 million pregnancies are affected by hyperglycemia during gestation. In recent years, numerous contemporary studies have demonstrated that the damage caused by diabetes is closely linked to female reproductive system dysfunctions and fetal health issues, thereby highlighting the significance of hyperglycemic pregnancies. The aim of this review is to provide a general and comparative perspective on the changes induced in the fetus by diabetes, experimentally modeled before and during pregnancy, throughout the gestational period

Özet

Gebelikte hiperglisemi, fetal komplikasyonlarla ilişkili diyabetik bir durum meydana getirir. Veriler incelendiğinde gebelerde diabetes mellitus oranı ile paralel artan fetal kayıplar ve olumsuz değişiklikler göze çarpmaktadır. Gebe kalma yaşının ilerlemesi ve her geçen gün uygun olmayan yaşam koşullarının artması ile hiperglisemik gebelikler ve buna bağlı olumsuz fetal değişiklikler artmakta ve neticede gelecek nesilleri etkileyecek global bir sağlık riski ortaya çıkmaktadır. Uluslararası Diyabet Federasyonu’nun sunduğu verilere göre, yaklaşık 21 milyon gebelik hiperglisemiden etkilenmektedir. Özellikle son yıllarda yapılan çok sayıda güncel çalışma, diyabetin meydana getirdiği hasarların dişi üreme sistemi ve fetal sağlık sorunları ile yakın ilişkide olduğunu göstermiş ve dolayısıyla hiperglisemik gebeliklerin önemini gözler önüne sermiştir. Bu derlemedeki amaç gebelik öncesinde ve gebelikte deneysel modellerle oluşturulmuş diyabetin, gebelik sürecinde fetüs üzerinde yapmış olduğu değişiklikler hakkında genel ve karşılaştırmalı bir bakış açısı sağlamaktır.

🔖

Cite This Article

Karaçetin, S., Ferah, M. A., Keçeci, M. (2026). Fetal Changes Associated with Hyperglycemic Pregnancies – An Experimental Perspective. Türkiye Diyabet ve Obezite Dergisi, Cilt: 10 Sayı: 1, 94–106. https://ajindex.com/articles/1436201

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (105)

  1. van den Arend IJM, Stolk RP, Krans HMJ, Grobbee DE, Schri jvers AJP. Management of type 2 diabetes: A challenge for pa tient and physician. Patient Educ Couns. 2000; 40(2): 187-194. doi: 10.1016/S0738-3991(99)00067-1.
  2. Yang T, Qi F, Guo F, Shao M, Song Y, Ren G, Linlin Z, Qin G, Zhao Y. An update on chronic complications of diabetes mellitus: From molecular mechanisms to therapeutic strate gies with a focus on metabolic memory. Mol Med. 2024; 30(1): 71. doi: 10.1186/s10020-024-00824-9.
  3. Karamanou M, Protogerou A, Tsoucalas G, Androutsos G, Poulakou-Rebelakou E. Milestones in the history of diabetes mellitus: The main contributors. World J Diabetes. 2016; 7(1): 1-7. doi: 10.4239/wjd.v7.i1.1.
  4. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021.
  5. Çetin Avcı S, Daşıkan Z. Prekonsepsiyonel, gebelik ve postpar tum döngüde maternal obeziteyi önlemek. Turk J Diab Obes. 2021; 5(3): 358-367. doi: 10.25048/tudod.927026.
  6. Cavnar Helvacı B, Candemir B, Cinel M, Hepşen S, Canlar Ş, Dağdeviren M, Çakal E. Assessing knowledge and aware ness of preconception care among women with type 1 diabe tes mellitus: Implications for optimizing maternal and fetal health outcomes. Turk J Diab Obes. 2025; 9(2): 204-211. doi: 10.25048/tudod.1701369.
  7. Harreiter J, Roden M. Diabetes mellitus: Definition, classifica tion, diagnosis, screening and prevention (update 2023). Wien Klin Wochenschr. 2023; 135(Suppl 1): 7-17. doi: 10.1007/ s00508-022-02122-y.
  8. Meroni G, Valerio A, Vezzoli M, Croci E, Carruba MO. The relationship between air pollution and diabetes: A study on the municipalities of the Metropolitan City of Milan. Di abetes Res Clin Pract. 2021; 174: 108748. doi: 10.1016/j.dia bres.2021.108748.
  9. Kırlangıç MM, Arici Halici BN. Evaluation of first trimester fasting blood glucose, HOMA-IR and HbA1c in prediction of gestational diabetes mellitus in non-obese pregnant women: A retrospective study. Turk J Diab Obes. 2022; 6(3): 267-273. doi: 10.25048/tudod.1198697.
  10. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, Karsidag K, Genc S, Telci A, Canbaz B, Turker F, Yilmaz T, Cakir B, Tuomilehto J; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and pre diabetes in Turkish adults. Eur J Epidemiol. 2013; 28(2): 169 180. doi: 10.1007/s10654-013-9771-5.
  11. Marquette GP, Klein VR, Niebyl JR. Efficacy of screening for gestational diabetes. Am J Perinatol. 1985; 2(1): 7-9. doi: 10.1055/s-2007-999901.
  12. American Diabetes Association. Classification and diagno sis of diabetes: Standards of medical care in diabetes—2023. Diabetes Care. 2023; 46(Suppl 1): S19-S40. doi: 10.2337/ dc23-S002.
  13. Ojo OA, Ibrahim HS, Rotimi DE, Ogunlakin AD, Ojo AB. Di abetes mellitus: From molecular mechanism to pathophysiol ogy and pharmacology. Med Nov Technol Devices. 2023; 19: 100247. doi: 10.1016/j.medntd.2023.100247.
  14. Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA. Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract. 2011; 93(Suppl 1): S52-S59. doi: 10.1016/S0168 8227(11)70014-6.
  15. Wu T, Rayner CK, Jones KL, Xie C, Marathe C, Horowitz M. Role of intestinal glucose absorption in glucose toler ance. Curr Opin Pharmacol. 2020; 55: 116-124. doi: 10.1016/j. coph.2020.10.017.
  16. Gurung P, Zubair M, Jialal I. Plasma glucose. StatPearls. 2024. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK541081/
  17. Eşrefoğlu M. Özel histoloji. İstanbul: Nobel Tıp Kitabevi; 2008. 18. Türkiye Diyabet Vakfı. Diyabet hakkında bilgiler. Available from: https://www.turkdiab.org/bilgiler.asp?lang=TR&id=67
  18. World Health Organization. Classification of diabetes melli tus. 2019. Available from: https://www.who.int/publications/i/ item/classification-of-diabetes-mellitus
  19. Garg SS, Gupta J. Polyol pathway and redox balance in di abetes. Pharmacol Res. 2022; 182: 106326. doi: 10.1016/j. phrs.2022.106326.
  20. Zhou M, Zhang Y, Shi L, Li L, Zhang D, Gong Z, Wu Q. Acti vation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions - A review. Pharmacol Res. 2024; 206: 107282. doi: 10.1016/j. phrs.2024.107282.
  21. Uceda AB, Mariño L, Casasnovas R, Adrover M. An overview on glycation: Molecular mechanisms, impact on proteins, pathogenesis, and inhibition. Biophys Rev. 2024; 16(2): 189 218. doi: 10.1007/s12551-024-01188-4.
  22. Mao L, Yin R, Yang L, Zhao D. Role of advanced glycation end products on vascular smooth muscle cells under diabetic ath erosclerosis. Front Endocrinol (Lausanne). 2022; 13: 983723. doi: 10.3389/fendo.2022.983723.
  23. Xiao Q, Wang D, Li D, Huang J, Ma F, Zhang H, Sheng Y, Zhang C, Ha X. Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes. J Diabetes Complications. 2023; 37(9): 108565. doi: 10.1016/j.jdiacomp.2023.108565.
  24. Newton AC. Protein kinase C: Perfectly balanced. Crit Rev Biochem Mol Biol. 2018; 53(2): 208-230. doi: 10.1080/10409238.2018.1442408.
  25. Guo J, Du L. Regulation of osteogenic differentiation in vascu lar smooth muscle cells under high-glucose condition. Front Endocrinol (Lausanne). 2025; 16: 1589160. doi: 10.3389/fen do.2025.1589160.
  26. Koya D, King GL. Protein kinase C activation and the develop ment of diabetic complications. Diabetes. 1998; 47(6): 859-866. doi: 10.2337/diabetes.47.6.859.
  27. Ishii H, Koya D, King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med (Berl). 1998; 76(1): 21-31. doi: 10.1007/ s001090050187.
  28. Pan D, Xu L, Guo M. The role of protein kinase C in diabetic microvascular complications. Front Endocrinol (Lausanne). 2022; 13: 973058. doi: 10.3389/fendo.2022.973058.
  29. Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tis sues of diabetes: Role of vascular NAD(P)H oxidase. J Am Soc Nephrol. 2003; 14(8 Suppl 3): S227-S232. doi: 10.1097/01. asn.0000077407.90309.65.
  30. Manoharan RR, Zachová K, Buzáš M, Pospíšil P, Křupka M, Prasad A. NADPH oxidase-dependent free radical generation and protein adduct formation in neutrophils. RSC Adv. 2024; 14(34): 24765-24780. doi: 10.1039/d4ra02739f.
  31. Cipriano A, Viviano M, Feoli A, Milite C, Sarno G, Castella no S, Sbardella G. NADPH oxidases: From molecular mecha nisms to current inhibitors. J Med Chem. 2023; 66(17): 11632 11655. doi: 10.1021/acs.jmedchem.3c00770.
  32. Paneque A, Fortus H, Zheng J, Werlen G, Jacinto E. The hexosamine biosynthesis pathway: Regulation and function. Genes (Basel). 2023; 14(4): 933. doi: 10.3390/genes14040933.
  33. Wang Y, Eshwaran R, Beck SC, Hammes HP, Wieland T, Feng Y. Contribution of the hexosamine biosynthetic pathway in the hyperglycemia-dependent and -independent breakdown of the retinal neurovascular unit. Mol Metab. 2023; 73: 101736. doi: 10.1016/j.molmet.2023.101736.
  34. TeSlaa T, Ralser M, Fan J, Rabinowitz JD. The pentose phos phate pathway in health and disease. Nat Metab. 2023; 5(8): 1275-1289. doi: 10.1038/s42255-023-00863-2.
  35. Ball LE, Berkaw MN, Buse MG. Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. Mol Cell Proteomics. 2006; 5(2): 313-323. doi: 10.1074/mcp.M500314-MCP200.
  36. Lee C, Kim SM, Kim DY, Han IO. O-GlcNAc cycling in neuroinflammation: From molecular mechanisms and ther apeutic perspectives. Neurobiol Dis. 2025; 217: 107160. doi: 10.1016/j.nbd.2025.107160.
  37. Cooksey RC, Hebert LF Jr, Zhu JH, Wofford P, Garvey WT, McClain DA. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fruc tose-6-phosphate amidotransferase: Decreased glucose trans porter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology. 1999; 140(3): 1151-1157. doi: 10.1210/endo.140.3.6563.
  38. White MR, Garcin ED. D-glyceraldehyde-3-phosphate dehy drogenase structure and function. Subcell Biochem. 2017; 83: 413-453. doi: 10.1007/978-3-319-46503-6_15.
  39. Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K. Association of glycemic indices (hyperglycemia, glucose variability and hypoglycemia) with oxidative stress and dia betic complications. J Diabetes Res. 2020; 2020: 7489795. doi: 10.1155/2020/7489795.
  40. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005; 54(6): 1615-1625. doi: 10.2337/diabetes.54.6.1615.
  41. Çetiner Ö, Rakıcıoğlu N. Hiperglisemi, oksidatif stres ve tip 2 diyabette oksidatif stres belirteçlerinin tanımlanması. Turk J Diab Obes. 2020; 4(1): 60-68. doi: 10.25048/tudod.638744.
  42. Paul A, Kumar M, Das P, Guha N, Rudrapal M, Zaman MK. Drug repurposing – A search for novel therapy for the treat ment of diabetic neuropathy. Biomed Pharmacother. 2022; 150: 113846. doi: 10.1016/j.biopha.2022.113846.
  43. American College of Obstetricians and Gynecologists. Gesta tional diabetes mellitus. Obstet Gynecol. 2018; 131(2): e49-e64. doi: 10.1097/AOG.0000000000002501.
  44. Mittal R, Prasad K, Lemos JRN, Arevalo G, Hirani K. Unveil ing gestational diabetes: An overview of pathophysiology and management. Int J Mol Sci. 2025; 26(5): 2320. doi: 10.3390/ ijms26052320.
  45. Sel G, Seyhan Baydağ S, Barut A, Akdemir AY, Özmen Ü, Har ma M, Harma M. Gebelerde ilk trimester plazma D vitamini düzeyleri ile gestasyonel diyabet arasında ilişki var mı? Turk J Diab Obes. 2020; 4(1): 36-40. doi: 10.25048/tudod.700771.
  46. Calvo MJ, Parra H, Santeliz R, Bautista J, Luzardo E, Villasmil N, Martínez MS, Chacín M, Cano C, Checa-Ros A, D’Marco L, Bermúdez V, De Sanctis JB. The placental role in gestational diabetes mellitus: A molecular perspective. TouchREV Endo crinol. 2024; 20(1): 10-18. doi: 10.17925/EE.2024.20.1.5.
  47. Field CP, Cleary EM, Thung SF, Venkatesh K, Buschur EO. Pregestational diabetes mellitus. Endotext. 2025.
  48. Türkiye Endokrinoloji ve Metabolizma Derneği. Diyabetes mellitus ve komplikasyonlarının tanı, tedavi ve izlem kılavuzu. Ankara: TEMD Yayınları; 2024.
  49. T.C. Sağlık Bakanlığı. Türkiye Diyabet Programı 2023–2027. Ankara: T.C. Sağlık Bakanlığı; 2023.
  50. International Federation of Gynecology and Obstetrics. The FIGO initiative on gestational diabetes mellitus: A pragmat ic guide for diagnosis, management, and care. Int J Gynecol Obstet. 2015; 131(Suppl 3): S173-S211. doi: 10.1016/S0020 7292(15)30033-3.
  51. Dodd JM, Crowther CA, Antoniou G, Baghurst P, Robinson JS. Screening for gestational diabetes: The effect of varying blood glucose definitions in the prediction of adverse mater nal and infant health outcomes. Aust N Z J Obstet Gynaecol. 2007; 47(4): 307-312. doi: 10.1111/j.1479-828X.2007.00743.x.
  52. Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L, Hoeg feldt CA, Powe CE, Immanuel J, Karuranga S, Divakar H, Levitt N, Li C, Simmons D, Yang X; IDF Diabetes Atlas Com mittee Hyperglycaemia in Pregnancy Special Interest Group. IDF diabetes atlas: Estimation of global and regional gesta tional diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s criteria. Diabetes Res Clin Pract. 2022; 183: 109050. doi: 10.1016/j.dia bres.2021.109050.
  53. Bueno A, Sinzato YK, Sudano MJ, Alvarenga FdaC, Calderon IM, Rudge MV, Damasceno DC. Short and long-term reper cussions of experimental diabetes in embryofetal development. Diabetes Metab Res Rev. 2014; 30(7): 575-581. doi: 10.1002/ dmrr.2521.
  54. Malaza N, Masete M, Adam S, Dias S, Nyawo T, Pheiffer C. A systematic review to compare adverse pregnancy outcomes in women with pregestational diabetes and gestational diabe tes. Int J Environ Res Public Health. 2022; 19(17): 10846. doi: 10.3390/ijerph191710846.
  55. Poitout V, Robertson RP. Glucolipotoxicity: Fuel excess and beta-cell dysfunction. Endocr Rev. 2008; 29(3): 351-366. doi: 10.1210/er.2007-0023.
  56. Çalışkan L, Çolak H, Karakoyun Laçin B. Gestasyonel diy abetli gebelerde sağlıklı yaşam biçimi davranışları ve ilişkili faktörler: Bir kamu hastanesi örneği. Turk J Diab Obes. 2025; 9(2): 179-191. doi: 10.25048/tudod.1625814.
  57. van Gerwen J, Shun-Shion AS, Fazakerley DJ. Insulin signal ling and GLUT4 trafficking in insulin resistance. Biochem Soc Trans. 2023; 51(3): 1057-1069. doi: 10.1042/BST20221066.
  58. Drobiova H, Alhamar G, Ahmad R, Al-Mulla F, Al Madhoun A. GLUT4 trafficking and storage vesicles: Molecular archi tecture, regulatory networks and their disruption in insulin resistance. Int J Mol Sci. 2025; 26(15): 7568. doi: 10.3390/ ijms26157568.
  59. Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018; 19(11): 3342. doi: 10.3390/ijms19113342.
  60. Wu Y, Liu B, Sun Y, Du Y, Santillan MK, Santillan DA, Snet selaar LG, Bao W. Association of maternal prepregnancy dia betes and gestational diabetes mellitus with congenital anom alies of the newborn. Diabetes Care. 2020; 43(12): 2983-2990. doi: 10.2337/dc20-0261.
  61. Abdelmonem Mahrous RF, Ali Hassanin SH, Elemam Elbashir RE, Gasm Elseed H, Ahmed Elnour SE, Elsayid NN. Neonatal hypoglycemia and long-term pediatric neurodevelopmental outcomes: A systematic review. Cureus. 2025; 17(6): e86183. doi: 10.7759/cureus.86183.
  62. Ananth CV, Basso O. Impact of pregnancy-induced hyperten sion on stillbirth and neonatal mortality. Epidemiology. 2010; 21(1): 118-123. doi: 10.1097/EDE.0b013e3181c297af.
  63. Galtier F. Definition, epidemiology, risk factors. Diabetes Me tab. 2010; 36(6 Pt 2): 628-651. doi: 10.1016/j.diabet.2010.11.014.
  64. Petitt DJ, Bennett PH, Knowler WC, Baird HR, Aleck KA. Gestational diabetes mellitus and impaired glucose tolerance during pregnancy: Long-term effects on obesity and glucose tolerance in the offspring. Diabetes. 1985; 34(Suppl 2): 119 122. doi: 10.2337/diab.34.2.s119.
  65. Francis EC, Kechris K, Jansson T, Dabelea D, Perng W. Nov el metabolic subtypes in pregnant women and risk of early childhood obesity in offspring. JAMA Netw Open. 2023; 6(4): e237030. doi: 10.1001/jamanetworkopen.2023.7030.
  66. Erkul A, Erbaş O. Complications of gestational diabetes: An overview. J Exp Basic Med Sci. 2024; 5: 170-179. doi: 10.5606/ jebms.2024.1087.
  67. Han Y, Sun Q, Chen W, Gao Y, Ye J, Chen Y, Wang T, Gao L, Liu Y, Yang Y. New advances of adiponectin in regulating obesity and related metabolic syndromes. J Pharm Anal. 2024; 14(5): 100913. doi: 10.1016/j.jpha.2023.12.003.
  68. Lappas M, Hiden U, Desoye G, Froehlich J, Hauguel-de Mou zon S, Jawerbaum A. The role of oxidative stress in the patho physiology of gestational diabetes mellitus. Antioxid Redox Signal. 2011; 15(12): 3061-3100. doi: 10.1089/ars.2010.3765.
  69. Al Bekai E, Beaini CE, Kalout K, Safieddine O, Semaan S, Sa hyoun F, Ghadieh HE, Azar S, Kanaan A, Harb F. The hidden impact of gestational diabetes: Unveiling offspring complica tions and long-term effects. Life (Basel). 2025; 15(3): 440. doi: 10.3390/life15030440.
  70. Kalandyk-Osinko K, Baran J, Baran R, Gierek K, Juza A, Kraśnianin E, Januszek S, Blajer-Olszewska B, Kluz T, Dar mochwał-Kolarz D. The influence of gestational diabetes mellitus on maternal and neonatal outcomes: A retrospective study in Rzeszów, Poland. Med Sci Monit. 2024; 30: e943644. doi: 10.12659/MSM.943644.
  71. Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z. Diabetes during pregnancy: A maternal disease complicating the course of pregnancy with long-term deleterious effects on the off spring: A clinical review. Int J Mol Sci. 2021; 22(6): 2965. doi: 10.3390/ijms22062965.
  72. Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: A literature review. Ann Nutr Metab. 2015; 66(Suppl 2): 14-20. doi: 10.1159/000371628.
  73. Orgul G, Ayık T, Şahin D, Yücel A. İlk trimester tarama test biyobelirteçlerinin gestasyonel diyabetes mellitus ile ilişki si. Turk J Diab Obes. 2020; 4(1): 41-45. doi: 10.25048/tu dod.611537.
  74. Karcz K, Królak-Olejnik B. Impact of gestational diabetes mel litus on fetal growth and nutritional status in newborns. Nutri ents. 2024; 16(23): 4093. doi: 10.3390/nu16234093.
  75. Shimada H, Powell TL, Jansson T. Regulation of placental amino acid transport in health and disease. Acta Physiol (Oxf). 2024; 240(7): e14157. doi: 10.1111/apha.14157.
  76. Callanan S, Philippe K, Delahunt A, O’Keeffe LM, O’Neill KN, Yelverton CA, Phillips CM, Twomey PJ, McDonnell CM, Cody D, McAuliffe FM. Macrosomia and childhood growth trajectories from birth to 10 years of age: Findings from the ROLO longitudinal birth cohort study. J Obes. 2025; 2025: 8884369. doi: 10.1155/jobe/8884369.
  77. Çakmak Genç G, Karakaş Çelik S, Hazaloğlu M, Harma M, Dursun A. Gestasyonel diyabet ile IL8/CXCL8 rs4073 gen po limorfizmi arasındaki ilişkinin araştırılması. Turk J Diab Obes. 2023; 7(1): 66-71. doi: 10.25048/tudod.1198053.
  78. Flores-Le Roux JA, Sagarra E, Benaiges D, Hernandez-Rivas E, Chillaron JJ, Puig de Dou J, Mur A, Lopez-Vilchez MA, Pedro-Botet J. A prospective evaluation of neonatal hypogly caemia in infants of women with gestational diabetes mellitus. Diabetes Res Clin Pract. 2012; 97(2): 217-222. doi: 10.1016/j. diabres.2012.03.011.
  79. Diggikar S, Trif P, Mudura D, Prasath A, Mazela J, Ognean ML, Kramer BW, Galis R. Neonatal hypoglycemia and neuro developmental outcomes: An updated systematic review and meta-analysis. Life (Basel). 2024; 14(12): 1618. doi: 10.3390/ life14121618.
  80. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol. 2011; 204(6): 479-487. doi: 10.1016/j. ajog.2010.11.039.
  81. Yang F, Liu H, Ding C. Gestational diabetes mellitus and risk of neonatal respiratory distress syndrome: A systematic review and meta-analysis. Diabetol Metab Syndr. 2024; 16(1): 294. doi: 10.1186/s13098-024-01539-x.
  82. Kawakita T, Bowers K, Hazrati S, Zhang C, Grewal J, Chen Z, Sun L, Grantz KL. Increased neonatal respiratory morbidity associated with gestational and pregestational diabetes: A ret rospective study. Am J Perinatol. 2017; 34(11): 1160-1168. doi: 10.1055/s-0037-1604414.
  83. Mills JL. Malformations in infants of diabetic mothers. Birth Defects Res A Clin Mol Teratol. 2010; 88(10): 769-778. doi: 10.1002/bdra.20757.
  84. Al-Biltagi M, El Razaky O, El Amrousy D. Cardiac changes in infants of diabetic mothers. World J Diabetes. 2021; 12(8): 1233-1247. doi: 10.4239/wjd.v12.i8.1233.
  85. Obut M, Çayönü Kahraman N, Sucu S, Keleş A, Arat Ö, Yücel Çelik Ö, Bucak M, Çakır A, Şahin D, Yücel A. Comparison of feto-maternal outcomes between emergency and elective ce sarean deliveries in patients with gestational diabetes. Turk J Diab Obes. 2023; 7(1): 52-59. doi: 10.25048/tudod.1233486.
  86. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syn drome in childhood: Association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005; 115(3): e290-e296. doi: 10.1542/peds.2004-1808.
  87. Kaaja R, Rönnemaa T. Gestational diabetes: Pathogenesis and consequences to mother and offspring. Rev Diabet Stud. 2008; 5(4): 194-202. doi: 10.1900/RDS.2008.5.194.
  88. Xiang AH, Wang X, Martinez MP, Walthall JC, Curry ES, Page K, Buchanan TA, Coleman KJ, Getahun D. Association of maternal diabetes with autism in offspring. JAMA. 2015; 313(14): 1425-1434. doi: 10.1001/jama.2015.2707.
  89. Lee J, Lee NK, Moon JH. Gestational diabetes mellitus: Mechanisms underlying maternal and fetal complications. Endocrinol Metab (Seoul). 2025; 40(1): 10-25. doi: 10.3803/ EnM.2024.2264.
  90. Muller YL, Yueh YG, Yaworsky PJ, Salbaum JM, Kappen C. Caudal dysgenesis in Islet-1 transgenic mice. FASEB J. 2003; 17(10): 1349-1351. doi: 10.1096/fj.02-0856fje.
  91. Sirasanagandla SR, Ranganath Pai KS, Potu BK, Bhat KM. Protective effect of Cissus quadrangularis Linn. on diabetes induced delayed fetal skeletal ossification. J Ayurveda Integr Med. 2014; 5(1): 25-32. doi: 10.4103/0975-9476.128852.
  92. Krause A, Schwab KO, Trost J, Thill M, Kunze M, Seufert J, Hentschel R. Gestational diabetes mellitus: The role of IGF-1 and leptin in cord blood. J Perinat Med. 2025; 53(7): 937-944. doi: 10.1515/jpm-2024-0379.
  93. Antoniou MC, Quansah DY, Gilbert L, Arhab A, Schenk S, La croix A, Stuijfzand B, Horsch A, Puder JJ. Association between maternal and fetal inflammatory biomarkers and offspring weight and BMI during the first year of life in pregnancies with GDM: MySweetheart study. Front Endocrinol (Laus anne). 2024; 15: 1333755. doi: 10.3389/fendo.2024.1333755.
  94. Karakaş Çelik S, Yamak AS. Gestasyonel diyabette genetik ve epigenetik değişimler. Turk J Diab Obes. 2018; 2(1): 9-15.
  95. Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD. Gestational diabetes mellitus and long-term consequences for mother and offspring: A view from Denmark. Diabetologia. 2016; 59(7): 1396-1399. doi: 10.1007/s00125-016-3985-5.
  96. Shashikadze B, Flenkenthaler F, Stöckl JB, Valla L, Renner S, Kemter E, Wolf E, Fröhlich T. Developmental effects of (pre-) gestational diabetes on offspring: Systematic screening using omics approaches. Genes (Basel). 2021; 12(12): 1991. doi: 10.3390/genes12121991.
  97. Moazzen H, Lu X, Liu M, Feng Q. Pregestational diabetes induces fetal coronary artery malformation via reactive oxy gen species signaling. Diabetes. 2015; 64(4): 1431-1443. doi: 10.2337/db14-0190
  98. Lehtoranta L, Koskinen A, Vuolteenaho O, Laine J, Kytö V, Soukka H, Ekholm E, Räsänen J. Gestational hyperglycemia reprograms cardiac gene expression in rat offspring. Pediatr Res. 2017; 82(2): 356-361. doi: 10.1038/pr.2017.42.
  99. Golic M, Stojanovska V, Bendix I, Wehner A, Herse F, Haase N, Kräker K, Fischer C, Alenina N, Bader M, Schütte T, Schuchardt M, van der Giet M, Henrich W, Muller DN, Fel derhoff-Müser U, Scherjon S, Plösch T, Dechend R. Diabetes mellitus in pregnancy leads to growth restriction and epigen etic modification of the Srebf2 gene in rat fetuses. Hyperten sion. 2018; 71(5): 911-920. doi: 10.1161/HYPERTENSIONA HA.117.10782.
  100. Agarwal P, Brar N, Morriseau TS, Kereliuk SM, Fonseca MA, Cole LK, Jha A, Xiang B, Hunt KL, Seshadri N, Hatch GM, Doucette CA, Dolinsky VW. Gestational diabetes adversely affects pancreatic islet architecture and function in the male rat offspring. Endocrinology. 2019; 160(8): 1907-1925. doi: 10.1210/en.2019-00232.
  101. Salazar-García M, Reyes-Maldonado E, Revilla-Monsalve MC, Villavicencio-Guzmán L, Reyes-López A, Sánchez-Gó mez C. Importance of maternal diabetes on the chronolog ical deregulation of intrauterine development: An experi mental study in rat. J Diabetes Res. 2015; 2015: 354265. doi: 10.1155/2015/354265.
  102. Damasceno DC, Volpato GT, Calderon IMP, Rudge MVC. Oxidative stress and diabetes in pregnant rats. Anim Re prod Sci. 2002; 72(3-4): 235-244. doi: 10.1016/S0378 4320(02)00094-5.
  103. Gäreskog M, Cederberg J, Eriksson UJ, Wentzel P. Maternal diabetes in vivo and high glucose concentration in vitro in crease apoptosis in rat embryos. Reprod Toxicol. 2007; 23(1): 63-74. doi: 10.1016/j.reprotox.2006.08.009.
  104. Capobianco E, Fornes D, Linenberg I, Powell TL, Jans son T, Jawerbaum A. A novel rat model of gestational dia betes induced by intrauterine programming is associated with alterations in placental signaling and fetal overgrowth. Mol Cell Endocrinol. 2016; 422: 221-232. doi: 10.1016/j. mce.2015.12.020.
  105. Kiss AC, Lima PH, Sinzato YK, Takaku M, Takeno MA, Rudge MV, Damasceno DC. Animal models for clinical and gestational diabetes: Maternal and fetal outcomes. Diabetol Metab Syndr. 2009; 1(1): 21. doi: 10.1186/1758-5996-1-21.